What is NDC 14789-102?

14789-102 is the product NDC for Tirofiban Hydrochloride, Tirofiban hydrochloride 50 ug/mL injection, listed with the FDA by Nexus Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Nexus Pharmaceuticals LLC, NDC labeler code 14789. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tirofiban Hydrochloride?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tirofiban Hydrochloride NDC 14789-102

NDC codes

FDA NDC Directory

Product NDC (as listed)14789-102Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14789-0102Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14789-102-02	1478901020214789010202	1 BAG in 1 CARTON (14789-102-02) / 250 mL in 1 BAGMarketed from Sep 25, 2023
14789-102-10	1478901021014789010210	2 BAG in 1 CARTON (14789-102-10) / 250 mL in 1 BAGMarketed from Feb 10, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tirofiban Hydrochloride
Generic name (nonproprietary): tirofiban hydrochloride
Active ingredients: Tirofiban hydrochloride — 50 ug/mL
Dosage form: Injection
Route: Intravenous
Labeler: Nexus Pharmaceuticals LLCNDC labeler code 14789
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213947
Marketing start: Sep 25, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Platelet Aggregation (Physiologic effect)
Identifiers: Product ID 14789-102_2dfa5385-2e91-c26a-e063-6394a90a37aaSPL ID 2dfa5385-2e91-c26a-e063-6394a90a37aaSPL set ID 7731e46a-2121-441b-b090-12dcefe240f0RxCUI 1737466, 1737471UNII 6H925F8O5J
Pharmacologic class: Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414789010202 followed by a unit qualifier and the quantity

Package 14789-0102-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 12, 2025.

Indications (excerpt from the label)

Tirofiban Hydrochloride Injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Tirofiban Hydrochloride Injection is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 14789-102

What is NDC 14789-102?: 14789-102 is the product NDC for Tirofiban Hydrochloride, Tirofiban hydrochloride 50 ug/mL injection, listed with the FDA by Nexus Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tirofiban Hydrochloride.
What is the active ingredient?: Tirofiban hydrochloride.
Who is the labeler?: Nexus Pharmaceuticals LLC, NDC labeler code 14789. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tirofiban Hydrochloride?: 3 other product NDCs are listed under this name. See all Tirofiban Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tirofiban Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tirofiban Hydrochloride	Tirofiban hydrochloride 50 ug/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-417	25021-0417-84
Tirofiban Hydrochloride	Tirofiban hydrochloride 50 ug/mL	InjectionIntravenous	Nexus Pharmaceuticals LLC	14789-101	14789-0101-01
Tirofiban hydrochloridetirofiban	Tirofiban hydrochloride 12.5 mg/250mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-145	68083-0145-01

Other NDCs under ANDA 213947

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213947
Product	Strength	Form · route	Labeler	Product NDC
Tirofiban Hydrochloride	Tirofiban hydrochloride 50 ug/mL	InjectionIntravenous	Nexus Pharmaceuticals LLC	14789-101